MedTrace Logo

The Massachusetts General Hospital Optical Coherence Tomography Registry

NCT01110538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2714

Last updated 2025-12-29

No results posted yet for this study

Summary

Information will be collected prospectively in about 3,000 patients having Optical Coherence Tomography during cardiac catheterization. Subjects will be initially enrolled at sites outside of the United States, where Optical Coherence Tomography is approved by regulatory agencies. Subjects will be followed for up to 5 years.

Conditions

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Massachusetts General Hospital

    collaborator OTHER

  • Ik-Kyung Jang, MD, PhD

    lead OTHER

Principal Investigators

  • Ik-Kyung Jang, M.D., Ph.D. · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01110538 on ClinicalTrials.gov